|
1
|
Boyer LA, Lee TI, Cole MF, Johnstone SE,
Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG,
et al: Core transcriptional regulatory circuitry in human embryonic
stem cells. Cell. 122:947–956. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bi Y, He Y, Huang J, Su Y, Zhu GH, Wang Y,
Qiao M, Zhang BQ, Zhang H, Wang Z, et al: Functional
characteristics of reversibly immortalized hepatic progenitor cells
derived from mouse embryonic liver. Cell Physiol Biochem.
34:1318–1338. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zeineddine D, Hammoud AA, Mortada M and
Boeuf H: The Oct4 protein: More than a magic stemness marker. Am J
Stem Cells. 3:74–82. 2014.PubMed/NCBI
|
|
4
|
Chang TS, Wu YC, Chi CC, Su WC, Chang PJ,
Lee KF, Tung TH, Wang J, Liu JJ, Tung SY, et al: Activation of
IL6/IGFIR confers poor prognosis of HBV-related hepatocellular
carcinoma through induction of Oct4/NANOG expression. Clin Cancer
Res. 21:201–210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park SW, Do HJ, Ha WT, Han MH, Park KH,
Song H, Kim NH and Kim JH: Transcriptional activation of Oct4 by
the ETS transcription factor PEA3 in NCCIT human embryonic
carcinoma cells. FEBS Lett. 588:3129–3136. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guzel E, Karatas OF, Duz MB, Solak M,
Ittmann M and Ozen M: Differential expression of stem cell markers
and ABCG2 in recurrent prostate cancer. Prostate. 74:1498–1505.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chang CC, Shieh GS, Wu P, Lin CC, Shiau AL
and Wu CL: Oct-3/4 expression reflects tumor progression and
regulates motility of bladder cancer cells. Cancer Res.
68:6281–6291. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Z, Li X, Li C, Su Y, Fang W, Zhong C,
Ji W, Zhang Q and Su C: Transcription factor OCT4 promotes cell
cycle progression by regulating CCND1 expression in esophageal
carcinoma. Cancer Lett. 354:77–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Du Z, Jia D, Liu S, Wang F, Li G, Zhang Y,
Cao X, Ling EA and Hao A: October4 is expressed in human gliomas
and promotes colony formation in glioma cells. Glia. 57:724–733.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Borrull A, Ghislin S, Deshayes F, Lauriol
J, Alcaide-Loridan C and Middendorp S: Nanog and Oct4
overexpression increases motility and transmigration of melanoma
cells. J Cancer Res Clin Oncol. 138:1145–1154. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang QL, Zhao ZQ, Li JC, Liang Y, Yin JQ,
Zou CY, Xie XB, Zeng YX, Shen JN, Kang T and Wang J: Salinomycin
inhibits osteosarcoma by targeting its tumor stem cells. Cancer
Lett. 311:113–121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Martins-Neves SR, Lopes ÁO, do Carmo A,
Paiva AA, Simões PC, Abrunhosa AJ and Gomes CM: Therapeutic
implications of an enriched cancer stem-like cell population in a
human osteosarcoma cell line. BMC Cancer. 12:1392012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang Y, Dai H and Guo QN: TSSC3
overexpression reduces stemness and induces apoptosis of
osteosarcoma tumor-initiating cells. Apoptosis. 17:749–761. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Q, Huang J, Zhou N, Zhang Z, Zhang A,
Lu Z, Wu F and Mo YY: LncRNA loc285194 is a p53-regulated tumor
suppressor. Nucleic Acids Res. 41:4976–4987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Isin M and Dalay N: LncRNAs and neoplasia.
Clin Chim Acta. 444:280–288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bauderlique-Le Roy H, Vennin C,
Brocqueville G, Spruyt N, Adriaenssens E and Bourette RP:
Enrichment of human stem-like prostate cells with s-SHIP promoter
activity uncovers a role in stemness for the long noncoding RNA
H19. Stem Cells Dev. 24:1252–1262. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shahryari A, Rafiee MR, Fouani Y, Oliae
NA, Samaei NM, Shafiee M, Semnani S, Vasei M and Mowla SJ: Two
novel splice variants of SOX2OT, SOX2OT-S1 and SOX2OT-S2 are
coupregulated with SOX2 and Oct4 in esophageal squamous cell
carcinoma. Stem Cells. 32:126–134. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chinese National Institutes of Health, .
Ethics examination in biomedicine studies involving the human body.
Chinese National Institutes of Health; Beijing, China: 2007
|
|
19
|
Hu J, Fang Y, Cao Y, Qin R and Chen Q:
miR-449a regulates proliferation and chemosensitivity to cisplatin
by targeting cyclin D1 and BCL2 in SGC7901 cells. Dig Dis Sci.
59:336–345. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang L, Wang J, Wang Y, Fu Q, Lei YH, Nie
ZY, Qiu J and Bao TY: Protective effect of exogenous matrix
metalloproteinase-9 on chronic renal failure. Exp Ther Med.
7:329–334. 2014.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee SH, Koo BS, Kim JM, Huang S, Rho YS,
Bae WJ, Kang HJ, Kim YS, Moon JH and Lim YC: Wnt/β-catenin
signalling maintains self-renewal and tumourigenicity of head and
neck squamous cell carcinoma stem-like cells by activating
October4. J Pathol. 234:99–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiao H, Jiang N, Zhou B, Liu Q and Du C:
TAZ regulates cell proliferation and epithelial-mesenchymal
transition of human hepatocellular carcinoma. Cancer Sci.
106:151–159. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vaiphei K, Sinha SK and Kochhar R:
Comparative analysis of Oct4 in different histological subtypes of
esophageal squamous cell carcinomas in different clinical
conditions. Asian Pac J Cancer Prev. 15:3519–3524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li N, Deng W, Ma J, Wei B, Guo K, Shen W,
Zhang Y and Luo S: Prognostic evaluation of nanog, Oct4, Sox2,
PCNA, Ki67 and E-cadherin expression in gastric cancer. Med Oncol.
32:4332015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen ZS, Ling DJ, Zhang YD, Feng JX, Zhang
XY and Shi TS: Octamer-binding protein 4 affects the cell biology
and phenotypic transition of lung cancer cells involving
β-catenin/E-cadherin complex degradation. Mol Med Rep.
11:1851–1858. 2015.PubMed/NCBI
|
|
27
|
Jóźwicki W, Brożyna AA and Siekiera J:
Expression of Oct4A: The first step to the next stage of urothelial
bladder cancer progression. Int J Mol Sci. 15:16069–16082. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shen L, Qin K, Wang D, Zhang Y, Bai N,
Yang S, Luo Y, Xiang R and Tan X: Overexpression of Oct4 suppresses
the metastatic potential of breast cancer cells via Rnd1
downregulation. Biochim Biophys Acta. 1842:2087–2095. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li JP, Liu LH, Li J, Chen Y, Jiang XW,
Ouyang YR, Liu YQ, Zhong H, Li H and Xiao T: Microarray expression
profile of long noncoding RNAs in human osteosarcoma. Biochem
Biophys Res Commun. 433:200–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dong Y, Liang G, Yuan B, Yang C, Gao R and
Zhou X: MALAT1 promotes the proliferation and metastasis of
osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol.
36:1477–1486. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Q, Geng PL, Yin P, Wang XL, Jia JP
and Yao J: Down-regulation of long non-coding RNA TUG1 inhibits
osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J
Cancer Prev. 14:2311–2315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pasic I, Shlien A, Durbin AD, Stavropoulos
DJ, Baskin B, Ray PN, Novokmet A and Malkin D: Recurrent focal
copy-number changes and loss of heterozygosity implicate two
noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31
in osteosarcoma. Cancer Res. 70:160–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Y, Yao J, Meng H, Yu Z, Wang Z, Yuan
X, Chen H and Wang A: A novel long non-coding RNA,
hypoxia-inducible factor-2α promoter upstream transcript, functions
as an inhibitor of osteosarcoma stem cells in vitro. Mol Med Rep.
11:2534–2540. 2015.PubMed/NCBI
|
